HUTCHMED (HCM) Competitors $15.01 +0.18 (+1.21%) Closing price 04:00 PM EasternExtended Trading$15.02 +0.02 (+0.10%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HCM vs. QGEN, MRNA, BBIO, ELAN, VRNA, ROIV, GRFS, RVMD, RYTM, and LEGNShould you be buying HUTCHMED stock or one of its competitors? The main competitors of HUTCHMED include QIAGEN (QGEN), Moderna (MRNA), BridgeBio Pharma (BBIO), Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), Roivant Sciences (ROIV), Grifols (GRFS), Revolution Medicines (RVMD), Rhythm Pharmaceuticals (RYTM), and Legend Biotech (LEGN). These companies are all part of the "pharmaceutical products" industry. HUTCHMED vs. Its Competitors QIAGEN Moderna BridgeBio Pharma Elanco Animal Health Verona Pharma PLC American Depositary Share Roivant Sciences Grifols Revolution Medicines Rhythm Pharmaceuticals Legend Biotech HUTCHMED (NASDAQ:HCM) and QIAGEN (NYSE:QGEN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment. Which has higher valuation and earnings, HCM or QGEN? QIAGEN has higher revenue and earnings than HUTCHMED. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHUTCHMED$630.20M4.15$37.73MN/AN/AQIAGEN$1.98B5.23$83.59M$1.6927.53 Does the media prefer HCM or QGEN? In the previous week, QIAGEN had 20 more articles in the media than HUTCHMED. MarketBeat recorded 24 mentions for QIAGEN and 4 mentions for HUTCHMED. QIAGEN's average media sentiment score of 1.22 beat HUTCHMED's score of 0.33 indicating that QIAGEN is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HUTCHMED 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral QIAGEN 9 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is HCM or QGEN more profitable? QIAGEN has a net margin of 18.30% compared to HUTCHMED's net margin of 0.00%. QIAGEN's return on equity of 14.77% beat HUTCHMED's return on equity.Company Net Margins Return on Equity Return on Assets HUTCHMEDN/A N/A N/A QIAGEN 18.30%14.77%8.87% Do analysts prefer HCM or QGEN? HUTCHMED currently has a consensus price target of $28.00, indicating a potential upside of 86.54%. QIAGEN has a consensus price target of $49.69, indicating a potential upside of 6.77%. Given HUTCHMED's stronger consensus rating and higher probable upside, research analysts plainly believe HUTCHMED is more favorable than QIAGEN.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HUTCHMED 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00QIAGEN 0 Sell rating(s) 8 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.27 Do institutionals & insiders believe in HCM or QGEN? 8.8% of HUTCHMED shares are owned by institutional investors. Comparatively, 70.0% of QIAGEN shares are owned by institutional investors. 3.6% of HUTCHMED shares are owned by insiders. Comparatively, 9.0% of QIAGEN shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more volatility & risk, HCM or QGEN? HUTCHMED has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500. Comparatively, QIAGEN has a beta of 0.64, indicating that its stock price is 36% less volatile than the S&P 500. SummaryQIAGEN beats HUTCHMED on 12 of the 15 factors compared between the two stocks. Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCM vs. The Competition Export to ExcelMetricHUTCHMEDMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.59B$3.08B$5.69B$9.86BDividend YieldN/A2.29%4.01%4.02%P/E RatioN/A7.4359.6622.54Price / Sales4.15392.01536.51112.00Price / Cash51.6344.0537.7059.65Price / Book2.118.0710.576.59Net Income$37.73M-$53.98M$3.27B$265.83M7 Day Performance-6.77%-0.88%0.61%0.18%1 Month Performance-21.86%5.67%5.43%2.13%1 Year Performance-15.48%9.07%50.37%21.07% HUTCHMED Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCMHUTCHMED2.4338 of 5 stars$15.01+1.2%$28.00+86.5%-14.3%$2.59B$630.20M0.001,811QGENQIAGEN3.9473 of 5 stars$48.92-1.6%$49.69+1.6%+3.4%$11.06B$1.98B28.905,765Trending NewsAnalyst RevisionMRNAModerna4.5908 of 5 stars$25.35-6.5%$42.88+69.2%-68.8%$10.55B$3.06B-3.375,800BBIOBridgeBio Pharma4.1775 of 5 stars$47.29-3.6%$61.35+29.7%+111.1%$9.38B$235.81M-11.56400Analyst ForecastELANElanco Animal Health2.8082 of 5 stars$17.80-0.6%$17.33-2.6%+21.3%$8.90B$4.48B20.709,000VRNAVerona Pharma PLC American Depositary Share2.4457 of 5 stars$105.62+0.1%$109.00+3.2%+293.5%$8.64B$221.67M-106.6930Positive NewsROIVRoivant Sciences2.9817 of 5 stars$11.64-2.3%$16.50+41.8%-0.5%$8.14B$29.05M-16.63860Positive NewsGRFSGrifols3.5702 of 5 stars$9.82-3.3%$10.30+4.9%+9.7%$6.99B$7.81B8.3923,822RVMDRevolution Medicines4.3754 of 5 stars$35.67-3.6%$69.92+96.0%-10.1%$6.92BN/A-7.93250News CoveragePositive NewsRYTMRhythm Pharmaceuticals3.6087 of 5 stars$99.20-3.9%$101.57+2.4%+124.7%$6.86B$130.13M-32.96140News CoveragePositive NewsLEGNLegend Biotech3.8513 of 5 stars$34.60-2.7%$73.00+111.0%-39.3%$6.53B$627.24M-39.322,609Positive NewsAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies QGEN Alternatives MRNA Alternatives BBIO Alternatives ELAN Alternatives VRNA Alternatives ROIV Alternatives GRFS Alternatives RVMD Alternatives RYTM Alternatives LEGN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HCM) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HUTCHMED (China) Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share HUTCHMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access